Kite Pharma, Inc. KITE
No live quote for KITE yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 156.56
- Target (low)
- 88.00
- Target (mean)
- 156.56
- Target (high)
- 180.00
Ratings (-1m) 11 2 buy · 9 hold · 0 sell
- Strong buy0
- Buy2
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 11
- 2 months ago 13
- 3 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -1.49 | 0.0% | 10.98M | +49.6% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.70 | 0.0% | 11.16M | +127.4% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 42.43M | +91.4% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 218.49M | +414.9% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 28, 2017 | Wedbush | Upgrade | Underperform | Neutral |
| Aug 28, 2017 | Canaccord Genuity | Downgrade | Buy | Hold |
| Aug 27, 2017 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Aug 27, 2017 | BTIG Research | Downgrade | Buy | Neutral |
| Jul 12, 2017 | Maxim Group | Downgrade | — | Hold |
| Jun 7, 2017 | BTIG Research | Upgrade | — | Buy |
| May 8, 2017 | Wedbush | Downgrade | — | Underperform |
| Mar 12, 2017 | Standpoint Research | Downgrade | — | Hold |
| Mar 2, 2017 | Stifel Nicolaus | Downgrade | — | Hold |
| Mar 1, 2017 | Citigroup | Downgrade | — | Neutral |
| Feb 21, 2017 | Wells Fargo | Initiated | — | Market Perform |
| Jan 31, 2017 | Wedbush | Initiated | — | Neutral |
| Nov 20, 2016 | H.C. Wainwright | Initiated | — | Buy |
| Aug 29, 2016 | BTIG Research | Initiated | — | Neutral |
| Jul 5, 2016 | Barclays | Initiated | — | Equal-Weight |
| Jun 1, 2016 | Raymond James | Initiated | — | Outperform |
| Feb 24, 2016 | Citigroup | Initiated | — | Buy |
| Feb 1, 2016 | RBC Capital | Initiated | — | Outperform |
| Jan 28, 2016 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Jan 18, 2016 | FBR Capital | Upgrade | — | Outperform |
| Dec 14, 2015 | Standpoint Research | Upgrade | — | Buy |
| Nov 17, 2015 | Goldman Sachs | Initiated | — | Buy |
| Nov 12, 2015 | Standpoint Research | Downgrade | — | Hold |
| Aug 16, 2015 | Standpoint Research | Initiated | — | Buy |
| Jun 17, 2015 | Maxim Group | Initiated | — | Buy |
| Jan 8, 2015 | Mizuho | Initiated | — | Buy |
| Oct 27, 2014 | Canaccord Genuity | Initiated | — | Buy |
| Oct 1, 2014 | Guggenheim | Initiated | — | Buy |
| Jul 14, 2014 | Jefferies | Initiated | — | Buy |
| Jul 14, 2014 | Stifel Nicolaus | Initiated | — | Buy |